Posted by: admin on: December 13, 2011
Antidiabetic drug Liraglutide, reduces meal-related hyperglycemia (for 12 hours after administration) by increasing insulin secretion, delaying gastric emptying, and suppressing prandial glucagon secretion. But its safety is questionable since it is associated with pancreatitis, and increased calcitonin secretion associated with thyroid tumour in mice. Read on to know more. Team@CMHF